[Advances in the therapy of mycoses].
D000196:Actinomycosis / Q000188:drug therapy; D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use; D001228:Aspergillosis / Q000188:drug therapy; D001759:Blastomycosis / Q000188:drug therapy; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy; D002648:Child; D003453:Cryptococcosis / Q000188:drug therapy; D003881:Dermatomycoses / Q000188:drug therapy*; D005260:Female; D006118:Griseofulvin / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008172:Lung Diseases, Fungal / Q000188:drug therapy; D008271:Mycetoma / Q000188:drug therapy; D009181:Mycoses / Q000188:drug therapy*; D009262:Nails; D009617:Nocardia Infections / Q000188:drug therapy; D009761:Nystatin / Q000627:therapeutic use; D012871:Skin Diseases / Q000188:drug therapy; D013174:Sporotrichosis / Q000188:drug therapy; D013266:Stilbamidines / Q000627:therapeutic use; D013793:Thallium / Q000009:adverse effects; D014008:Tinea Pedis / Q000188:drug therapy
D013266:Stilbamidines; D009761:Nystatin; D006118:Griseofulvin; D000666:Amphotericin B; D013793:Thallium
Fortschritte der Therapie der Mykosen.